Literature DB >> 9384260

Delta9-tetrahydrocannabinol activates [Ca2+]i increases partly sensitive to capacitative store refilling.

C M Filipeanu1, D de Zeeuw, S A Nelemans.   

Abstract

Delta9-tetrahydrocannabinol induces [Ca2+]i increases in DDT1MF-2 smooth muscle cells. Both Ca2+ entry and release from intracellular Ca2+ stores were concentration dependently activated. The Ca2+ entry component contributed most to the increases in [Ca2+]i. Stimulation with delta9-tetrahydrocannabinol after functional downregulation of intracellular Ca2+ stores by longterm thapsigargin treatment, still induced a major Ca2+ entry and a minor Ca2+ release component. Thapsigargin sensitive influx and release were selectively inhibited by the cannabinoid CB1 receptor antagonist SR141716A. No effects on [Ca2+]i were obtained after stimulation with the CB2 receptor agonist palmitoylethanolamide. This study is the first demonstration of (1) Ca2+ release from thapsigargin sensitive intracellular stores and capacitative Ca2+ entry via CB1 receptor stimulation and of (2) an additional delta9-tetrahydrocannabinol induced thapsigargin insensitive component, mainly representing Ca2+ influx which is neither mediated by CB1 nor CB2 receptor stimulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9384260     DOI: 10.1016/s0014-2999(97)01254-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  Intracellular Angiotensin II and cell growth of vascular smooth muscle cells.

Authors:  C M Filipeanu; R H Henning; D de Zeeuw; A Nelemans
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Signal transduction of cannabinoid CB1 receptors in a smooth muscle cell line.

Authors:  M Begg; A Baydoun; M E Parsons; A Molleman
Journal:  J Physiol       Date:  2001-02-15       Impact factor: 5.182

3.  The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins.

Authors:  Jane E Lauckner; Bertil Hille; Ken Mackie
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

4.  Inhibitory signaling by CB1 receptors in smooth muscle mediated by GRK5/β-arrestin activation of ERK1/2 and Src kinase.

Authors:  Sunila Mahavadi; Wimolpak Sriwai; Jiean Huang; John R Grider; Karnam S Murthy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-09       Impact factor: 4.052

5.  An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction.

Authors:  C R Hutch; C J Hillard; C Jia; C C Hegg
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

Review 6.  CB1 and CB2 Receptor Pharmacology.

Authors:  Allyn C Howlett; Mary E Abood
Journal:  Adv Pharmacol       Date:  2017-06-12

7.  Anandamide-induced mobilization of cytosolic Ca2+ in endothelial cells.

Authors:  J V Mombouli; G Schaeffer; S Holzmann; G M Kostner; W F Graier
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

8.  Δ9-THC increases endogenous AHA1 expression in rat cerebellum and may modulate CB1 receptor function during chronic use.

Authors:  Catalin M Filipeanu; Jesse J Guidry; Stuart T Leonard; Peter J Winsauer
Journal:  J Neurochem       Date:  2011-08-16       Impact factor: 5.372

9.  Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.

Authors:  E Gkoumassi; B G J Dekkers; M J Dröge; C R S Elzinga; M Schmidt; H Meurs; J Zaagsma; S A Nelemans
Journal:  Br J Pharmacol       Date:  2007-06-11       Impact factor: 8.739

10.  (Endo)cannabinoids mediate different Ca2+ entry mechanisms in human bronchial epithelial cells.

Authors:  Effimia Gkoumassi; Bart G J Dekkers; Melloney J Dröge; Carolina R S Elzinga; Rutger E Hasenbosch; Herman Meurs; S Adriaan Nelemans; Martina Schmidt; Johan Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-03-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.